Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT04089267 · COMPLETED
Trial details
- NCT number
- NCT04089267
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.